Announcing the Iterative Mapping Early Access Program!

Starting in January 2026, the Nautilus Iterative Mapping Early Access Program enables you to be one of the first to generate single-molecule proteomic data using Nautilus’ single-molecule Iterative Mapping approach. The program will give you exclusive, early access to Iterative Mapping first as a fee-for-service offering through Nautilus Proteomics Analysis Services followed by a small number of instrument placements ahead of full launch in late 2026. All projects accepted into the program are run in coordination with Nautilus. We will help you design, run, and analyze your experiments ensuring you get the most out of your Iterative Mapping data.

Participants will be part of a limited group of researchers with early access to Iterative Mapping. Our first offering through the program is the Nautilus Tau Proteoforms assay, which enables exploration of critical aspects of tau proteoform biology. Tau proteoforms are not accessible with existing proteomics methods and may be key to developing the next generation of biomarkers and drug targets for neurodegenerative diseases. The program will expand with additional offerings in 2026.

If you’re interested in the Nautilus Tau Proteoforms assay, would like to use Iterative Mapping for a different application, or simply wish to stay informed about new capabilities, please fill out the form on the Iterative Mapping Early Access Program webpage.